Pharmaceuticals & Life Sciences Experience


Advising Ratiopharm of Teva Pharmaceutical Industries, the world’s leading generic pharmaceutical company, in patent litigation over the client's generic product that allegedly infringed the Latvian patent of Pfizer's famous drug Viagra.

Assisting Merck Serono, a division of a leading company for innovative and top-quality high-tech products in the pharmaceutical and chemical sectors, in reviewing template contracts for support and funding of healthcare professionals or hospitals in Estonia, Latvia and Lithuania.

Advising a global healthcare leader engaged in the research, development, manufacturing and marketing of innovative therapeutic solutions, on aspects related to clinical trials, as well as representing the client in negotiations with health care institutions in Belarus.

Advising Quintiles, a global leader in pharmaceutical services, on regulatory and clinical trial issues. Assisting on registration of corporate changes in Lithuania related to complex share transfer transactions in the company group.

Advising a pharmaceutical company devoted to finding better solutions for tackling infectious diseases, on regulation of donation of medicinal products and use of free samples in the Baltics.

Advising a major global research company in healthcare products and therapies on protection of sensitive personal data. Our pan-Baltic advice covered processing sensitive personal data in multiple jurisdictions and recommendations on how to optimise reporting duties.

Advising Vitabalans, a Finnish pharmaceutical company, on pricing reimbursable and non-reimbursable medicinal products in Lithuania.

Assisting Oriola, a Scandinavian leader in the pharmaceutical trade, in re-registration of the pharmacy licence for the newly acquired Matisa pharmacy in Latvia under a business transfer agreement.

Advising and representing a division of a leading company in innovative and top-quality high-tech products in the pharmaceutical and chemical sectors in a dispute with the National Health Service on application of Latvian law.

Advising Pharmsyntez, a leading publicly listed Russian pharmaceutical company, on legal aspects of doing business in Belarus, including incorporation of a joint venture with a local research institution.

Advising a global pharmaceutical company on the Estonian legal framework regarding distribution and warehousing of pharmaceuticals. The case involved complex analysis of warehousing requirements for pharmaceuticals in the case of different distribution models.


Advising a global pharmaceutical and medical devices company on competition and tax aspects related to providing discounts on medical devices compensated by the National Health Insurance Fund in Lithuania. Continuously advising on public procurement and other regulatory matters.

Advising a major global direct selling company (through an international law firm) on the requirements for entry of medical devices to the Estonian, Latvian and Lithuania markets.

Advising AGA, a member of Linde Group, a world leading supplier of industrial, process and speciality gases, on registration and re-registration of medical devices (medical gas equipment) in Latvia.

Advising St. Jude Medical, a global medical device company headquartered in St. Paul, Minnesota, United States, in setting up a local subsidiary in Estonia and providing current legal advice on legal aspects in corporate law, procurement law and others.

Advising a top-100 global retailer on distribution of medical devices in Latvia. Advice included analysis of regulatory requirements related to product authorisation and CE-marking, as well as product marketing and licensing.


Acting as national rapporteur for a study on the overview of national laws on electronic health records (EHR) in the EU Member States and their interaction with provision of cross-border eHealth services at the request of the Executive Agency for Health and Consumers (EAHC) of the European Commission. Sorainen prepared national reports for an overview of national laws on electronic health records for Estonia, Latvia and Lithuania.

Advising a leading private general hospital in Lithuania on regulatory and reimbursement matters.

Advising IT service provider in Lithuania on regulatory and taxation aspects related to launching an online healthcare consultation service, allowing clients to schedule a visit and obtain a consultation on healthcare related issues from a medic in the respective field.

Advising a leading Russian chain of clinical diagnostics laboratories on aspects related to entry to the Lithuanian market, including advice on franchising regulation, regulatory matters and regulation of healthcare and diagnostic lab services, as well as on related tax issues.


Advising the world’s leading cosmetic company on trademark protection issues, use of trademarks in advertisements and issues related to corporate and commercial contracts.

Advising a leading distributor of food supplements in Lithuania on trademark registration and related issues and providing legal advice on regulatory compliance.

Advising Innothera, an international company in the field of medical and para-pharmaceutical products for women's health and treatment of diseases, in connection with its operations in Belarus.


Advising Bayer HealthCare Pharmaceuticals, a global marketer of over-the-counter (OTC) medications and nutritional supplements, on acquisition of Sagmel Inc, a US pharmaceutical company involved in developing, manufacturing and marketing OTC drugs and nutritional supplements, with activities in the Baltics and Belarus. In addition to legal due diligence, the transaction involved, in particular, creation of new corporate structures and acquisition of assets in Belarus.

Acting as pan-Baltic counsel for Pamplona Capital Partners III LP (a specialist investment manager with an assets portfolio of over EUR 4.4 billion) in acquiring a majority stake in the Alvogen Group, an international specialty pharmaceutical company focused on the development, manufacture and marketing of generic pharmaceuticals, biosimilar products and OTCs, with commercial operations in 30 countries around the world. In cooperation with Allen & Overy, Sorainen advised the client in respect of the operations of Alvogen in Lithuania, Latvia and Estonia.

Advising Citigroup Venture Capital Internationalon acquisition of a minority shareholding in Sanitas (one of the largest pharmaceutical companies in Lithuania) and the related acquisition by Sanitas of Jelfa Pharmaceutical Company S.A., one of the largest pharmaceutical companies in Poland. We also assisted Citigroup Venture Capital International in acquiring an additional 20% shareholding in Sanitas for EUR 30 million. 

Advising Oriola, a Finnish-listed retail and wholesale distributor of pharmaceuticals and health and wellbeing products, on the sale of its Baltic business to Oribalt Group, controlled by the management of Oriola Baltic subsidiaries. Sorainen, as lead counsel on the sell side, structured the deal and prepared transaction documentation, including a framework share purchase agreement encompassing full divestment of shares in five target companies established in three different countries.

Home Expertise Sector groups